Main navigation

• Home
• Our medicines
• Diseases and conditions
• Community support
• Help affording your medicines
• Research & development
• Healthcare professionals
• Careers
• About AstraZeneca US
  • Investors
  • Our company
  • AZ on the issues
  • Responsible business
  • Newsroom
    • Media resources
    • All news
    • Corporate news
    • Financial news
    • Product news
    • Research news
  • US web sites
  • Contact us

You are here

• Home
• About AstraZeneca US
• Newsroom

• Product news

The following shows headlines of all product-related news articles published within 12-months, starting from most recent.

• Pages
• Previous
• 1
• 2
• 3
• Next

• • Jun 2, 2009
  • AstraZeneca studies show relief of nighttime heartburn and reduction in GERD-related sleep disturbances  
• • May 20, 2009
  • Court grants AstraZeneca preliminary injunction against Apotex in PULMICORT RESPULES patent litigation  
• • May 18, 2009
  • AstraZeneca announces TOPROL-XL® (metoprolol succinate) is now available  
• • May 4, 2009
  • AstraZeneca submits NDA for low dose aspirin/esomeprazole combination product  
• • Apr 16, 2009
  • Court grants AstraZeneca temporary restraining order against Apotex in PULMICORT RESPULES® patent litigation  
• • Apr 9, 2009
  • FDA Advisory Committee recommendation on SEROQUEL XR Supplemental New Drug Applications  
• • Apr 6, 2009
  • AstraZeneca receives FDA Complete Response Letter on SYMBICORT for the treatment of asthma in children 6 to 11 years old  
• • Apr 3, 2009
  • FDA Advisory Committee documents for SEROQUEL XR available on AstraZeneca web site  
• • Mar 30, 2009
  • Patients receiving hemodialysis for treatment of end stage renal disease did not benefit from statin therapy in the AURORA study  
• • Mar 29, 2009
  • CRESTOR® reduced risk of blood clots in the veins  

• Pages
• Previous
• 1
• 2
• 3
• Next

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed